Will Spooren is section head of behavioral pharmacology and preclinical imaging at Hoffman-La Roche and coordinator of EU-AIMS.
Will Spooren
Head of behavioral pharmacology and preclinical imaging
F. Hoffmann-La Roche
From this contributor
Questions for Will Spooren: Paving a path to autism drugs
A European initiative that aims to provide a framework for clinical trials in autism has developed tools to track treatment responses.
Questions for Will Spooren: Paving a path to autism drugs
By
Ingrid Wickelgren
13 October 2015 | 6 min read
Explore more from The Transmitter
‘Digital sphinx’ raises questions about connectome models
The sphinx, with a worm’s brain and a fly’s body, illustrates the potential pitfalls of using deep-learning techniques to model biological processes.
‘Digital sphinx’ raises questions about connectome models
The sphinx, with a worm’s brain and a fly’s body, illustrates the potential pitfalls of using deep-learning techniques to model biological processes.
By
Natalia Mesa
2 April 2026 | 5 min read
Taking a closer look at astrocytes and autism
These glial cells are increasingly linked to neurodevelopmental conditions and the regulation of social behaviors and anxiety.
Taking a closer look at astrocytes and autism
These glial cells are increasingly linked to neurodevelopmental conditions and the regulation of social behaviors and anxiety.
By
The Transmitter
2 April 2026 | 2 min read
Neuro’s ark: Sounding out the evolution of hearing with geckos
Catherine Carr explains her discovery that geckos retain a vibration-sensing pathway previously thought to be lost when animals moved onto land.
Neuro’s ark: Sounding out the evolution of hearing with geckos
Catherine Carr explains her discovery that geckos retain a vibration-sensing pathway previously thought to be lost when animals moved onto land.
By
Helena Kudiabor
1 April 2026 | 5 min read